Drug details

Triferic AVNU (ferric pyrophosphate citrate injection)

type of Iron Products

Triferic AVNU (ferric pyrophosphate citrate injection) is an iron replacement product indicated for the replacement of iron to maintain hemoglobin in adult patients with hemodialysis-dependent chronic kidney disease (HDD-CKD).

This drug may have the following side effects:

• fever,
• headache,
• fatigue,
• urinary tract infection (UTI),
• pain in extremities,
• muscle spasms,
• procedural low blood pressure (hypotension),
• shortness of breath
• swelling of extremities,
• back pain, and
• weakness/lethargy,
• AV fistula thrombosis,
• AV fistula site hemorrhage,

The following drugs are related to Triferic AVNU, either as a replacement or used together:

• Anadrol-50 (oxymetholone)
• BiferaRx (folic acid heme iron polypeptide iron dextran, cyanocobalamin tablets)
• Procrit (epoetin alfa)
• Epogen (epoetin alfa)
• Retacrit (epoetin alfa-epbx injection)
• FeRiva (highly soluble oral tablets)
• Glofil-125 (sodium iothalamate i-125 injection solution)
• NuFera (iron supplement tablets)
• Revlimid (lenalidomide)